Viridian Therapeutics, Inc.VRDNNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q3 2025 | 93993.33% |
| Q2 2025 | 4.17% |
| Q1 2025 | 0.00% |
| Q4 2024 | -16.28% |
| Q3 2024 | 19.44% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | -26.53% |
| Q1 2023 | -6.67% |
| Q4 2022 | -91.21% |
| Q3 2022 | 366.80% |
| Q2 2022 | 18.52% |
| Q1 2022 | 0.93% |
| Q4 2021 | 2.88% |
| Q3 2021 | -80.92% |
| Q2 2021 | -24.88% |
| Q1 2021 | 2587.04% |
| Q4 2020 | 0.00% |
| Q3 2020 | -100.00% |
| Q2 2020 | -79.71% |
| Q1 2020 | -5.91% |
| Q4 2019 | 26.62% |
| Q3 2019 | -72.35% |
| Q2 2019 | 575.81% |
| Q1 2019 | -21.85% |
| Q4 2018 | -49.58% |
| Q3 2018 | -56.74% |
| Q2 2018 | -54.39% |
| Q1 2018 | 301.34% |
| Q4 2017 | -26.92% |
| Q3 2017 | 127.16% |
| Q2 2017 | 55.41% |
| Q1 2017 | -38.89% |
| Q4 2016 | -14.96% |
| Q3 2016 | 1.72% |
| Q2 2016 | 6.85% |
| Q1 2016 | 24.13% |
| Q4 2015 | 31.54% |